The Lung Cancer Research Foundation and Pfizer Global Medical Grants are collaborating to offer a new research grant opportunity focused on understanding ways to improve clinical practices for side effect management for non-small cell lung cancer (NSCLC) patients receiving targeted therapies. This collaborative funding mechanism is designed to support innovative health services research proposals that leverage multidisciplinary approaches to improve the management of targeted therapy toxicities. Proposals on a variety of topics including the following are encouraged:
- Patterns of use and comparisons of real-world versus pre-approval patient experiences
- Defining and understanding tolerability (including late toxicities and patient reported outcomes)
- Role of diverse, multi-disciplinary teams (including pharmacists, dieticians, caregivers, etc.) and coordination of care in managing and monitoring therapy
- Real-time symptom monitoring and implementation science
Approaches to management of toxicities in NSCLC patients treated with tyrosine kinase inhibitors, including but not limited to ALK, ROS1, and/or EGFR inhibitors, fall within the scope of this project. Through this initiative, Pfizer and LCRF will support up to three innovative health services research projects. Specifically, up to $350,000 will be provided over a period of two years to investigators at US-based institutions. Additional eligibility details and application instructions may be found in the full request for proposals.
The LCRF Pilot Grant Program supports high-risk, high-reward research projects investigating a wide variety of topics related to lung cancer. Eligible areas of research include but are not limited to:
- Improving our understanding of lung cancer biology
- Prevention and screening for early detection
- Identification of new biomarkers and the development of targeted therapies
- Development of more effective and safer therapies
- Psychosocial research including supportive measures for people with lung cancer and their families
- Quality of care and outcomes research for the improvement of healthcare standards and overall patient outcomes
LCRF Pilot Grants provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators (within ten years of faculty appointment). For full details, please refer to the request for proposals on the LCRF Pilot Grant Program award page.
With support from the Stavros S. Niarchos Foundation for Charity in memory of Kathryn Louloudis, LCRF will fund two research projects in 2019 with a focus on overcoming disparities in lung cancer. These grants will provide $150,000 over a period of two years to investigators of any career level. For complete details, please refer to the request for proposals and full details on the award page.